The Rise of Remote Patient Monitoring in Europe

Healthcare delivery across Europe is undergoing a structural shift, and remote patient monitoring (RPM) has become a central component of this transformation. Rather than being viewed as an emerging technology, RPM is now increasingly integrated into mainstream healthcare models, supporting better outcomes for patients and more sustainable care delivery for healthcare systems.
For companies looking to enter or expand in Europe, understanding how RPM is applied across different healthcare contexts is essential. Adoption varies by country and care setting, but the underlying drivers are consistent: ageing populations, rising chronic disease prevalence, and increasing pressure on healthcare capacity.
This article explores where and how RPM is being used across Europe and what this means for companies considering the European market.
How does Europe’s healthcare structure affect RPM adoption?
Europe does not operate a single healthcare system. Instead, each country maintains its own structure, funding models, and regulatory frameworks.
RPM solutions must therefore adapt to both centralised systems, such as those found in countries like the United Kingdom, and more decentralised models seen in countries such as Germany and France. Despite these differences, adoption is progressing across Europe, driven by common challenges around access, efficiency, and long‑term care management.
Successful RPM deployment depends on aligning technology with local reimbursement pathways, clinical workflows, and data protection requirements.
What role does RPM play in chronic disease management?
One of the most established use cases for remote patient monitoring in Europe is chronic disease management.
Conditions such as diabetes, cardiovascular disease, respiratory illnesses, and hypertension require ongoing monitoring rather than episodic treatment. RPM allows patients to track vital signs, medication adherence, and lifestyle factors from home, while clinicians can access data remotely and intervene when thresholds are exceeded.
This proactive model of care supports earlier intervention, reduces avoidable hospital admissions, and improves long‑term disease control. For healthcare systems under strain, RPM enables more efficient allocation of clinical resources while maintaining quality of care.
How does RPM improve access in rural and underserved areas?
Access to healthcare services remains uneven across Europe, particularly in rural or underserved regions.
RPM helps bridge this gap by reducing the need for frequent in‑person visits and enabling clinicians to monitor patients remotely. Through connected devices and secure digital platforms, healthcare providers can deliver follow‑up care, review patient data, and adjust treatment plans without geographic limitations.
This model improves continuity of care and helps reduce disparities by making healthcare services more accessible regardless of patient location.
Why is RPM increasingly important in elderly care?
Europe’s ageing population has increased demand for long‑term and home‑based care solutions.
RPM supports elderly patients by enabling continuous monitoring of vital signs, mobility indicators, and medication adherence in the home environment. This reduces unnecessary hospital visits, supports independent living, and allows earlier detection of health deterioration.
Countries with a higher proportion of older adults have increasingly integrated RPM into home care and community‑based healthcare models as part of broader efforts to reduce pressure on hospitals.
What does RPM mean for manufacturers and solution providers?
For manufacturers, the European RPM market presents both opportunity and complexity.
Success depends not only on technological capability, but also on compliance with European regulatory requirements, data protection frameworks, and reimbursement environments. Product design must prioritise usability, interoperability, and clinical relevance to support adoption by healthcare professionals and patients alike.
Manufacturers that invest in innovation, data integration, and partnerships with local stakeholders are better positioned to achieve long‑term market traction.
Key takeaways
- Remote patient monitoring is becoming a core component of healthcare delivery across Europe
- Adoption is driven by ageing populations, chronic disease prevalence, and healthcare capacity pressure
- RPM supports chronic disease management, elderly care, and access in rural or underserved regions
- Europe’s fragmented healthcare systems require country‑specific RPM strategies
- Success in the European RPM market depends on regulatory compliance, usability, and local alignment
Written by the MedTech & Life Sciences team at EuroDev.
FAQ's
-
Remote patient monitoring refers to the use of connected devices and digital platforms to collect and transmit patient health data from outside traditional clinical settings.
-
Growth is driven by ageing populations, increasing chronic disease prevalence, and the need to reduce pressure on hospitals while maintaining care quality.
-
Yes, but adoption varies by country depending on healthcare structure, reimbursement models, and regulatory frameworks.
-
RPM is commonly used in chronic disease management, elderly care, post‑acute monitoring, and in improving access to care in remote areas.
-
Yes. RPM solutions must comply with EU medical device regulations, data protection rules, and country‑specific healthcare requirements.
Category
Related articles
-
MDR vs. FDA 510(k): Where U.S. Playbooks Break in Europe (and How to Fix Them)
Last updated: 2 March 2026Learn the key differences between FDA 510(k) and EU MDR, including classification changes, clinical...
Read more -
Expanding Non-Invasive Monitoring Tech into Europe: A Path for North American Innovators
Last updated: 26 August 2025Europe’s healthcare systems need scalable, non-invasive monitoring tools. Discover key...
Read more -
Navigating the European Market: Challenges and Opportunities for American Medical Companies
Last updated: 23 July 2025Europe’s medical device market offers huge growth potential for American MedTech companies, but...
Read more

